Narcotics analgesics also identified as opioids are the medications that imitate the activity of endorphins, elements produced by the body to regulate pain. Opioids are used to treat acute pain associated with surgery and other medical procedures, as well as for persistent (chronic) and advance pain. They are also used to induce anesthesia, cough syrups, and to suppress diarrhea. These drugs are offered via prescription only. Since opioids are addictive and may result in fatal overdose, thus sue of narcotics analgesics is strictly regulated by the governments.
Narcotics Analgesics Market – Drivers
Increase in the research for narcotics analgesics drugs is projected to rise the growth of global the market during the forecasted period. For instance, a phase III clinical study by Loma Linda University is undergoing for drug Narco. The objective of the study is to evaluate patient pain level in the immediate post-operative period and quantify pain medication usage in patients who undergo outpatient Ear, Nose, and Throat (ENT) surgeries. The study was started in February 2018, and is estimated to complete in January 2019.
Furthermore, Temple University along with AstraZeneca is undergoing clinical phase II study to assess the effect of opioids on esophageal motility. The study found that chronic opioid users are suffering with esophageal motor dysfunctioning. This study will explore the safety and tolerability of MOVANTIK (Naloxegol) and is expected to improve opioid- induced esophageal motility disorders. The study was started in January 2017 and is expected to complete in January 2020.
Narcotics Analgesics Market – Restraint
Shortages of narcotics analgesics medications is likely to alter the growth of narcotics analgesics market. For instance, according to the Drug Enforcement Administration (DEA) of U.S. February 2018, hospitals and other healthcare providers in U.S. are currently facing critical shortages of a number of injectable opioid medications, including morphine, hydromorphone, and fentanyl. Injectable opioids are critical to treating the pain needs of patients undergoing interventional procedures such as cardiac catheterization and surgeries. Diminished supply of these critical drugs, can lead to less efficient pain control for patients since opioid analgesics are highly potent in pain control.
Narcotics Analgesics Market – Regional Analysis
On the basis of region, the global narcotics analgesics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Geographically, North America is likely to lead in the global narcotics analgesics market owing to rising misuse of opioid analgesics. For instance, according to the Federal Government of U.S., in 2015, 8.5 million people i.e. 3% of the population of U.S. misused opioid painkillers in 2015, and 2.5 million were addicted to either painkillers or heroin in 2015. Moreover, More than 33,000 people died from overdoses of opioid drugs in 2015.
Europe region is also expected to perceive extensive growth in global narcotics analgesics market since few countries in the European Union are misusing prescription opioid analgesics as normal pain killers which is not advisable since these are habit forming drugs. For instance, according to BMC Psychiatry journal August 2016, Spain had the highest use of opioids for non-medical purposes, and Great Britain had the second-highest opioid users.
The key players operating in narcotics analgesics market include, Pfizer Inc., Teva Pharmaceuticals, Allergan plc, BioDelivery Sciences International, Inc., Endo Pharmaceuticals, Inc., Akron, Inc., UCB, Inc., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, and Janssen Pharmaceuticals, Inc.
Narcotics Analgesics Market – Taxonomy
By Product Type
- Pain Management
- Neuropathic Pain
- Back Pain
- Cancer Pain
- Cough Treatment
- Diarrhea Treatment
- North America
- Asia Pacific
- Latin America
- Middle East